The mission of the UGA Center for Molecular Medicine (CMM) is to better understand the molecular and cellular basis of human disease, and then to use this information for the development of new therapies, cures and diagnostics.
Every research program within the CMM has a clear link to one or more human disease and will be directed towards translating this research into the discovery of new therapies, cures and diagnostic tools. Therapeutics developed may be in the form of stem cell-based therapies, vaccines, new drugs, antibodies or protein pharmaceuticals. Research programs will also focus on the identification of new biomarkers and other tools that have utility in clinical diagnostics. This has direct applications to a wide range of diseases including cancer, cardiovascular disease, neurological disorders and diabetes.
Interactions with other UGA Centers and Institutes
The Center works closely and synergistically with allied research centers and institutes at the University of Georgia. These include: the Center for Drug Discovery (CDD), the Center for Tropical and Emerging Global Disease (CTEGD), the UGA Developmental Biology Program, the UGA Cancer Center and the Complex Carbohydrate Research Center (CCRC).
Interactions with clinicians
The CMM also provides an interface between UGA investigators and researchers/clinicians at Augusta University (formerly Georgia Regents University), including those in the GRU-UGA Medical Partnership, as well as other clinicians in the Athens area who participate in research related to human health and disease.